Literature DB >> 18595012

Do we need a "three-star" hospital to cure a gastric cancer?

Yasuhiro Kodera.   

Abstract

Entities:  

Mesh:

Year:  2008        PMID: 18595012     DOI: 10.1007/s10120-008-0469-4

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


× No keyword cloud information.
  9 in total

1.  The debate is over; it's time to move on.

Authors:  Nicholas J Petrelli
Journal:  J Clin Oncol       Date:  2004-04-13       Impact factor: 44.544

2.  Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial.

Authors:  Roderich E Schwarz; David D Smith
Journal:  J Clin Oncol       Date:  2005-08-10       Impact factor: 44.544

3.  Nodal dissection for patients with gastric cancer: a randomised controlled trial.

Authors:  Chew-Wun Wu; Chao A Hsiung; Su-Shun Lo; Mao-Chin Hsieh; Jen-Hao Chen; Anna Fen-Yau Li; Wing-Yiu Lui; Jacqueline Whang-Peng
Journal:  Lancet Oncol       Date:  2006-04       Impact factor: 41.316

4.  Extended lymph-node dissection for gastric cancer.

Authors:  J J Bonenkamp; J Hermans; M Sasako; C J van de Velde; K Welvaart; I Songun; S Meyer; J T Plukker; P Van Elk; H Obertop; D J Gouma; J J van Lanschot; C W Taat; P W de Graaf; M F von Meyenfeldt; H Tilanus
Journal:  N Engl J Med       Date:  1999-03-25       Impact factor: 91.245

5.  Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: the effect of undertreatment.

Authors:  Scott A Hundahl; John S Macdonald; Jacqueline Benedetti; Thomas Fitzsimmons
Journal:  Ann Surg Oncol       Date:  2002-04       Impact factor: 5.344

6.  Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial.

Authors:  H H Hartgrink; C J H van de Velde; H Putter; J J Bonenkamp; E Klein Kranenbarg; I Songun; K Welvaart; J H J M van Krieken; S Meijer; J T M Plukker; P J van Elk; H Obertop; D J Gouma; J J B van Lanschot; C W Taat; P W de Graaf; M F von Meyenfeldt; H Tilanus; M Sasako
Journal:  J Clin Oncol       Date:  2004-04-13       Impact factor: 44.544

7.  Rationale for gastrectomy with D2 lymphadenectomy in the treatment of gastric cancer.

Authors:  Alvaro Díaz de Liaño; Concepción Yarnoz; Rubén Aguilar; Cristina Artieda; Héctor Ortiz
Journal:  Gastric Cancer       Date:  2008-07-02       Impact factor: 7.370

8.  Skeletonizing en-bloc gastrectomy for adenocarcinoma in Caucasian patients.

Authors:  Jean-Marie Collard; Jacques Malaise; Jean-Yves Mabrut; Paul-Jacques Kestens
Journal:  Gastric Cancer       Date:  2003       Impact factor: 7.370

9.  Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer.

Authors:  M Degiuli; M Sasako; A Ponti; F Calvo
Journal:  Br J Cancer       Date:  2004-05-04       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.